{"id":44445,"date":"2022-05-27T17:01:37","date_gmt":"2022-05-27T15:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/"},"modified":"2022-05-27T17:01:37","modified_gmt":"2022-05-27T15:01:37","slug":"correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/","title":{"rendered":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit"},"content":{"rendered":"
\n

\nTechnology-enabled solutions blending best-of-breed population health management and SDoH tools with expert services and consulting to help providers succeed with ACO REACH<\/i>\n<\/p>\n

SAN FRANCISCO–(BUSINESS WIRE)–The fifth paragraph of release dated April 21, 2022 has been changed to correct quote attribution.\n<\/p>\n

<\/a><\/p>\n

\nThe updated release reads:\n<\/p>\n

\nINNOVACCER UNVEILS ACO REACH ACCELERATOR TOOLKIT<\/b>\n<\/p>\n

\nTechnology-enabled solutions blending best-of-breed population health management and SDoH tools with expert services and consulting to help providers succeed with ACO REACH<\/i>\n<\/p>\n

\nToday Innovaccer Inc.<\/a>, the Health Cloud company, launched its ACO REACH Accelerator toolkit<\/a>, an innovative technology-enabled suite designed to help accountable care organizations succeed in the ACO REACH model<\/a> recently announced by the Centers for Medicare & Medicaid Services (CMS). The ACO REACH model was developed by CMS to advance health equity by bringing accountable care to underserved communities, and to support momentum around provider-led organizations moving from fee-for-service to risk-based payment models.\n<\/p>\n

\nInnovaccer\u2019s ACO REACH Accelerator toolkit brings a suite of technology and services together that can help providers jump start and excel at this new value-based model: the Innovaccer Health Cloud\u2019s Data Activation Platform<\/a>, Innovaccer\u2019s industry-leading population health management solution<\/a>, Innovaccer\u2019s world-class population health analytics<\/a>; and Innovaccer\u2019s comprehensive SDoH solution<\/a> for identifying, understanding, and mitigating social determinants\u2014an absolute essential for supporting health equity, access to care, and community health. These innovative technologies will be complemented with a selection of tools, consulting, and advisory services that can provide a comprehensive approach to becoming and excelling as a REACH ACO.\n<\/p>\n

\n\u201cMany providers are interested in becoming REACH ACOs, but they\u2019ll need the right people, processes, and technologies to help develop, implement, and optimize their shared savings strategies,\u201d says Dr. Brian Silverstein, chief population health officer at Innovaccer. \u201cAs a technology-enabled service, the ACO REACH Accelerator toolkit offers our customers an array of tools and services intended to help them succeed in ACO REACH\u2019s total capitation program.\u201d\n<\/p>\n

\nSpecifically, Innovaccer\u2019s ACO REACH Accelerator toolkit can help provide:\n<\/p>\n

    \n
  1. \nPopulation Health Management: <\/b>Innovaccer\u2019s Population Health Management<\/a>, an intuitive and customizable solution that can help REACH ACOs achieve better health outcomes, improve the patient experience, and reduce costs. The solution\u2019s analytics, data integration, and automated care management workflow components help ACOs improve care management and patient engagement.<\/p>\n<\/li>\n
  2. \nSDoH Management: <\/b>Innovaccer\u2019s Social Vulnerability Index (SVI)<\/a> supports actionable social determinants of health (SDoH) with SVI scores down to the individual patient level, which helps paint an accurate picture of risk and optimize care. With our proprietary methodology, providers will be equipped to stratify the social risk of their population by identifying patients\u2019 susceptibility to socioeconomic factors that can impact population health; integrating these factors to create a holistic patient record that drives targeted social interventions; identifying and trending social determinants regionally or nationally to develop mitigation programs; and more.<\/p>\n<\/li>\n
  3. \nFinancial Management Services<\/b>: Our roadmap includes Innovaccer partners who will be able to provide claims adjudication; financial analytics by Innovaccer experts to help equip ACOs to establish downstream contracts with participating and preferred providers, provide total cost of care forecasting; forecast performance with benchmarks and assumptions from similar organizations; perform sensitivity testing on risk, quality, and expenses; deploy program adjustments such as risk-scores, quality measures, provider incentives; and more to be made available over the coming year.<\/p>\n<\/li>\n
  4. \nExpert Consulting and Advisory Services: <\/b>Our growing network of experienced consulting partners will be able to provide expert advice to help providers develop and optimize their shared savings strategies, and provide risk readiness assessment services to prepare for and best align their organization for success with ACO REACH over the coming year.<\/p>\n<\/li>\n
  5. \nSocial Assistance Services: <\/b>Digital access to a broad network of low-cost or no-cost community resources. Providers can easily connect patients to the largest national network of free or low-cost community resources, addressing over 58 social factors across more than 300 service types. Application tools provide integrated communication between care managers, community resource workers, and patients. Point-of-care integration provides support for closed-loop referrals between providers and social workers.\n<\/li>\n<\/ol>\n

    \n\u201cInnovaccer is offering a population health platform that takes into consideration some of the new driving factors under the ACO REACH model,\u201d said Tamra Ruymann, MBA, Chief of Digital Health for PSW, a population health company. \u201cThese include social determinants of health assessments and demographic data collection to advance health equity for ACOs.\u201d\n<\/p>\n

    \nAccelerate your performance in ACO REACH with Innovaccer\u2019s ACO REACH Accelerator toolkit. For more information, please visit https:\/\/innovaccer.com\/solutions\/aco-reach<\/a>.\n<\/p>\n

    \nAbout Innovaccer<\/b>\n<\/p>\n

    \nInnovaccer Inc., the Health Cloud company, is a leading San Francisco-based healthcare technology company committed to accelerating innovation in healthcare. The Innovaccer\u00ae<\/sup> Health Cloud unifies patient data across systems and settings, and empowers healthcare organizations to rapidly develop scalable, modern applications that improve clinical, operational, and financial outcomes. Innovaccer\u2019s solutions have been deployed across more than 1,000 care settings in the U.S., enabling more than 37,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped organizations unify health records for more than 24 million people and generate more than $600 million in savings. Innovaccer is the #1 rated Data and Analytics Platform by KLAS, and the #1 rated population health technology platform by Black Book. For more information, please visit innovaccer.com<\/a>.\n<\/p>\n

    Contacts<\/b> <\/p>\n

    \nPress Contact:
    \n
    Sachin Saxena
    \n
    Innovaccer Inc.
    \n
    \u200bsachin_saxena@innovaccer.com<\/a>
    415-504-3851\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    Technology-enabled solutions blending best-of-breed population health management and SDoH tools with expert services and consulting to help providers succeed with ACO REACH SAN FRANCISCO–(BUSINESS WIRE)–The fifth paragraph of release dated April 21, 2022 has been changed to correct quote attribution. The updated release reads: INNOVACCER UNVEILS ACO REACH ACCELERATOR TOOLKIT Technology-enabled solutions blending best-of-breed population … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44445","6":"format-standard","7":"category-industry"},"yoast_head":"\nCORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Technology-enabled solutions blending best-of-breed population health management and SDoH tools with expert services and consulting to help providers succeed with ACO REACH SAN FRANCISCO–(BUSINESS WIRE)–The fifth paragraph of release dated April 21, 2022 has been changed to correct quote attribution. The updated release reads: INNOVACCER UNVEILS ACO REACH ACCELERATOR TOOLKIT Technology-enabled solutions blending best-of-breed population ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-27T15:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit\",\"datePublished\":\"2022-05-27T15:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/\"},\"wordCount\":886,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220421005789\\\/en\\\/1428422\\\/21\\\/Innovaccer_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/\",\"name\":\"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220421005789\\\/en\\\/1428422\\\/21\\\/Innovaccer_Logo.jpg\",\"datePublished\":\"2022-05-27T15:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220421005789\\\/en\\\/1428422\\\/21\\\/Innovaccer_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220421005789\\\/en\\\/1428422\\\/21\\\/Innovaccer_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend","og_description":"Technology-enabled solutions blending best-of-breed population health management and SDoH tools with expert services and consulting to help providers succeed with ACO REACH SAN FRANCISCO–(BUSINESS WIRE)–The fifth paragraph of release dated April 21, 2022 has been changed to correct quote attribution. The updated release reads: INNOVACCER UNVEILS ACO REACH ACCELERATOR TOOLKIT Technology-enabled solutions blending best-of-breed population ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-27T15:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit","datePublished":"2022-05-27T15:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/"},"wordCount":886,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/","name":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg","datePublished":"2022-05-27T15:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220421005789\/en\/1428422\/21\/Innovaccer_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-innovaccer-unveils-aco-reach-accelerator-toolkit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING Innovaccer Unveils ACO REACH Accelerator Toolkit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44445"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44445\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}